Revision history of "Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials" (Q38397460)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

25 October 2022

  • curprev 06:2906:29, 25 October 2022 KrBot talk contribs 48,383 bytes −1 Set a claim value: title (P1476): Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials undo
  • curprev 06:2906:29, 25 October 2022 KrBot talk contribs 48,384 bytes −1 Changed Dutch label: Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials undo (restore)
  • curprev 06:2906:29, 25 October 2022 KrBot talk contribs 48,385 bytes −1 Changed English label: Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials undo (restore)
  • curprev 06:2906:29, 25 October 2022 KrBot talk contribs 48,386 bytes −1 Changed Asturian label: Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials undo (restore)

12 October 2022

7 October 2021

21 June 2021

20 June 2021

21 May 2021

15 October 2020

10 June 2020

5 August 2019

16 December 2018

30 October 2018

25 August 2018

8 November 2017

6 September 2017

2 September 2017